My account:




  remember me

Enter   Register
Information
All rights reserved. Any reprinting of materials of the site is possible only with the written permission of administration and with a direct hyperlink to this site.

(#2 2014)



Ãîä:   2019   |   2018   |   2017   |   2016   |   2015   |   2014   |   2013   |   2012   |   2011   |   2010

Íîìåð:   4    |    3    |    2    |    1

INTERNATIONAL EXPERIENCE

Multi-Criteria Decision Analysis as a Tool to Support Decision Making: a Review of its Methods and Their Applicability to Health Technology Assessment

V.K. Fedyaeva1 , V.V. Omelyanovsky1, 2, O.Yu. Rebrova1, 3 
1 Russian Presidential Academy of National Economy and Public Administration (RANEPA), Moscow, Russia
2 Financial Scientific Research Institute of the Ministry of Finance of Russia, Moscow, Russia 
3 N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia, Moscow, Russia
Recent Achievements of the European Project EUnetHTA

L.V. Maksimova1, 2, V.V. Omelyanovskiy1, 2, M.V. Avxentyeva1, 3
1 Center for Health Technology Assessment of the Institute for Applied Economic Research at the Russian Presidential Academy of National Economy and Public Administration (RANEPA), Moscow, Russia 
2 Center for Healthcare Funding of the Financial Scientific Research Institute of the Ministry of Finance of Russia, Moscow, Russia 
3 The I.M. Sechenov First Moscow State Medical University, Moscow, Russia
METHODOLOGY

Early Health Technology Assessment as a Tool for Evaluating and Steering the Creation of New Medical Products

V.V. Omelyanovsky1, 2 
1 Center for Health Technology Assessment of the Institute for Applied Economic Research at the Russian Presidential Academy of National Economy and Public Administration (RANEPA), Moscow, Russia 
2 Center for Healthcare Funding of the Financial Scientific Research Institute at the Ministry of Finance of Russia
On the Registration of Clinical Trials Conducted in the Russian Federation and Publication of Their Results

O.Yu. Rebrova1, 2, V.S. Dombrovsky2 
1 N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia, Moscow, Russia 
2 Russian Presidential Academy of National Economy and Public Administration (RANEPA), Moscow, Russia
Model Conceptialization in Health Technology Assessment

S.Ch. Djalalov, D.K. Djalalova, J.S. Hoch
Cancer Care Ontario, Canadian Cancer Agency, Toronto, Canada
MANAGEMENT IN HEALTH CARE

Clinical and Economic Grounds for Implementing a System of Outpatient Provision of Medications to Working-Age Hypertensive Patients in the Russian Federation

M.V. Sura1 , M.V. Avxentyeva1, 3, V.V. Omelyanovsky1, 2, D.V. Fedyaev1, 2, N.S. Andreyeva4 , D.A. Zateyschikov5 , T.V. Fofanova6 
1 Center for Health Technology Assessment of the Russian Presidential Academy of National Economy and Public Administration (RANEPA), Moscow, Russia 
2 Center for Healthcare Funding of the Financial Scientific Research Institute at the Ministry of Finance of Russia 
3 I.M. Sechenov First Moscow State Medical University, Moscow, Russia 
4 National Center for Health Technology Assessment, Moscow, Russia 
5 City Clinical Hospital No. 51, Moscow, Russia 
6 Healthcare Research Center at the Russian Cardiology Research and Production Complex, Moscow, Russia
ORIGINAL RESEARCH

Life Expectancy is Related to the Factors Which, According to RIA Rating Agency, Determine the Quality of Life

S.A. Boytsov, I.V. Samorodskaya, M.A. Vatolina
National Research Center for Preventive Medicine of the Ministry of Health of Russia, Moscow
Pharmacoeconomic Evaluation of Ranolazine in Russian Patients with Angina Pectoris

S.G. Gorokhova1, 2, V.V. Ryazhenov1, 3, V.D. Gorokhov2 , S.A. Maximkin3 
1 I.M. Sechenov First Moscow State Medical University, Moscow, Russia 
2 Scientific Clinical Center “RzhD” 
3 Center for Strategic Healthcare Research “High-quality Medical Technologies”
Comparitive Clinical and Economic Analysis of the Use of Nucleoside Reverse Transcriptase Inhibitor in the Form of Fixed Dose Combination with the Patients Who Have No Experience in Anti-Retroviral Therapy of AIDS

E.A. Pyadushkina1, 2, V.I. Ignatyeva2, 3, V.V. Omelyanovsky2, 4 
1 Autonomous Nonprofit Organization “National Health Technology Assessment Centre”, Moscow 
2 Centre for Health Technology Assessment of the Russian Presidential Academy of National Economy and Public Administration (RANEPA), Moscow 
3 I.M. Sechenov First Moscow State Medical University, Moscow, Russia 
4 Center for Healthcare Funding of the Financial Scientific Research Institute at the Ministry of Finance of Russia, Moscow, Russia
© 2019 Health Technology Assessment in Russia. Send a message         |